Vaccine News and Research

Latest Vaccine News and Research

People urged to take up life-saving COVID-19 booster vaccines ahead of Christmas

From tomorrow, the National Booking Service will open to people aged 40-49 for their booster jab, and young people aged 16-17 for their second jab.

21 Nov 2021

Booster or third dose for outbound international travel to be added to NHS COVID Pass

Travelers who have had a booster or a third dose will be able to demonstrate their vaccine status through the NHS COVID Pass from Friday 19 November.

21 Nov 2021

Study underscores why COVID-19 vaccine boosters are important for all adults

As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.

21 Nov 2021

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors - a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions - generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

New evidence that host immunity drives evolution of the dengue virus

New research by a team of University of Florida investigators, and others, provides evidence that host immunity drives evolution of the dengue virus.

20 Nov 2021

Trial positions single-dose HPV vaccination as a high impact public health intervention

In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.

20 Nov 2021

CDC expands recommendations for COVID-19 booster dose to include all adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) expanded recommendations for booster shots to include all adults ages 18 years and older who received a Pfizer-BioNTech or Moderna vaccine at least six months after their second dose.

19 Nov 2021

Effectiveness of COVID-19 vaccination during Delta variant predominance

A new study investigated the continued effectiveness of COVID-19 vaccination during the delta variant predominance in a diverse and urban healthcare setting.

19 Nov 2021

COVID-19 induced excess mortality

A new study presented a generalized linear mixed model to determine the rate of mortality related to COVID-19 infection in Lombardy, Italy.

19 Nov 2021

Can you take the COVID-19 and Influenza vaccines on the same day?

Scientists have conducted a substudy within a phase 3 UK trial and have reported the safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with licensed seasonal influenza vaccines.

19 Nov 2021

Vaccine-or-test requirements increase work and costs for governments

Amanda Kostroski, a 911 dispatcher in Madison, Wisconsin, leaves her busy job once a week to go to a county health clinic to be tested for covid-19.

19 Nov 2021

Population-based risk compensation may have been a driving force in UK's COVID pandemic

The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. Despite a diminishing protective effect against infection and onward transmission after vaccination, and a slightly diminished effect with the Delta variant compared to the Alpha variant, protection against severe outcomes remains high.

19 Nov 2021

UCLA study shows how COVID vaccination is critical to controlling the pandemic

A study currently available on the medRxiv* preprint server has demonstrated that the incidence and mortality rates of coronavirus disease 2019 (COVID-19) in the US can be significantly reduced at the population level by increasing vaccinate rates from 40% to 80%.

18 Nov 2021

A nasal COVID vaccine using a weakened influenza vector

The authors of a new study, published on the bioRxiv* preprint server, constructed a COVID-19 nasal vaccine candidate by inserting a gene encoding the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2, named CA4-dNS1-nCoV-RBD (dNS1-RBD) in a live attenuated influenza virus (LAIV) vector.

18 Nov 2021

Seroprevalence study in Tamil Nadu shows antibody decline following SARS-CoV-2 infection and vaccination

In the sixth-most populated state of India – Tamil Nadu, three rounds of a district-level serological study were conducted through two COVID waves.

18 Nov 2021

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

A recent study assesses the efficacy of repeat doses of REGEN-COV in SARS-CoV-2-negative adults who were healthy or had chronic medical conditions.

18 Nov 2021

Public health measures should be continued alongside covid-19 vaccination, suggest experts

Several personal protective and social measures, including handwashing, mask wearing, and physical distancing are associated with reductions in the incidence covid-19 and should be continued alongside vaccination, suggest experts after reviewing the latest evidence in The BMJ today.

18 Nov 2021

Vaccine News and Research

Latest Vaccine News and Research

People urged to take up life-saving COVID-19 booster vaccines ahead of Christmas

Booster or third dose for outbound international travel to be added to NHS COVID Pass

Study underscores why COVID-19 vaccine boosters are important for all adults

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

New evidence that host immunity drives evolution of the dengue virus

Trial positions single-dose HPV vaccination as a high impact public health intervention

CDC expands recommendations for COVID-19 booster dose to include all adults

Effectiveness of COVID-19 vaccination during Delta variant predominance

COVID-19 induced excess mortality

Can you take the COVID-19 and Influenza vaccines on the same day?

Vaccine-or-test requirements increase work and costs for governments

Population-based risk compensation may have been a driving force in UK's COVID pandemic

UCLA study shows how COVID vaccination is critical to controlling the pandemic

A nasal COVID vaccine using a weakened influenza vector

Seroprevalence study in Tamil Nadu shows antibody decline following SARS-CoV-2 infection and vaccination

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

Public health measures should be continued alongside covid-19 vaccination, suggest experts

KHN’s ‘What the Health?’: Boosting confusion

What is the public perception surrounding COVID immunity certificates?

Study finds no strong evidence that COVID-19 vaccination is linked to menstrual changes

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in